Bisphosphonate related osteonecrosis of the jaws: Clinico-pathological investigation and histomorphometric analysis

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

Volumn 115, Issue 5, 2013, Pages 660-666

  Anavi Lev, Karen ^a   Anavi, Yakir ^b,c   Chaushu, Gavriel ^b,c   Alon, Dror M ^b,c   Gal, Gavriel ^b   Kaplan, Ilana ^b,c  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID;

ACTINOMYCES; ACTINOMYCOSIS; ADULT; AGED; ARTICLE; BACTERIAL LOAD; BREAST TUMOR; COMPARATIVE STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS ADMINISTRATION; ISOLATION AND PURIFICATION; ISRAEL; JAW OSTEONECROSIS; MALE; MICROBIOLOGY; MIDDLE AGED; MULTIPLE MYELOMA; ORAL DRUG ADMINISTRATION; OSTEOMYELITIS; OSTEOPOROSIS; PHYSIOLOGY; PROSTATE TUMOR; RETROSPECTIVE STUDY; RISK FACTOR; TIME; VERY ELDERLY; WOUND HEALING;

ACTINOMYCES; ACTINOMYCOSIS; ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; BACTERIAL LOAD; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; BREAST NEOPLASMS; DIABETES COMPLICATIONS; DIPHOSPHONATES; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISRAEL; MALE; MIDDLE AGED; MULTIPLE MYELOMA; OSTEOMYELITIS; OSTEOPOROSIS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; WOUND HEALING;

EID: 84876585120     PISSN: 22124403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oooo.2013.03.001     Document Type: Article

References (40)

1. M.S. Greenberg, M. Glick, and J.A. Ship Burket's Oral Medicine Diagnosis and Treatment 11th ed. 2008 BC Decker Hamilton Ontario 482 483
2. B.W. Neville, D.D. Damm, C.M. Allen, and J.E. Bouquot Oral and Maxillofacial Pathology 3rd ed. 2009 WB Saunders Philadelphia 203 205
3. G. Pulvere, H. Schutt-Gerowitt, and K.P. Schaal Human cervicofacial actinomycoses: microbiological data for 1997 cases Clin Infect Dis 37 2003 490 497 (Pubitemid 37011771)
4. M. Miller, and A.J. Haddad Cervicofacial actinomycosis Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 1998 496 508 (Pubitemid 128643611)
5. R. Nagler, M. Peled, and D. Laufer Cervicofacial actinomycosis Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83 1997 652 656
6. C. Madrid, K. Bouferrache, M. Abarca, B. Jaques, and M. Broome Bisphosphonate-related osteonecrosis of the jaws: how to manage cancer patients Oral Oncol 46 2010 468 470
7. S. Otto, M.H. Abu-Id, and S. Fedele Osteoporosis and bisphosphonate- related osteonecrosis of the jaw: not just a sporadic coincidence-a multi-centre study J Craniomaxillofac Surg 39 2011 272 277
8. R.E. Marx Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic J Oral Maxillofac Surg 61 2003 1115 1117 (Pubitemid 37064711)
9. G.M. Kushner, and B. Alpert Bisphosphonate-related osteonecrosis of the jaws Curr Opin Otolaryngol Head Neck Surg 19 2011 302 306
10. S.L. Ruggiero Bisphosphonate-related osteonecrosis of the jaw: an overview Ann N Y Acad Sci 1218 2011 38 46
11. T.S. Lazarovici, R. Yahalom, S. Tiacher, S. Elad, I. Hardan, and N. Yarom Bisphosphonate-related osteonecrosis of the jaws: a single-center study of 101 patients J Oral Maxillofac Surg 67 2009 850 855
12. M. Kos, J.F. Kuebler, K. Luczak, and W. Engelke Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk J Craniomaxillofac Surg 38 2010 255 259
13. G. Lugassy, R. Shaham, A. Nemets, D. Ben-Dor, and O. Nahlieli Severe osteomyelitis of the jaw in long-term survivors of multiple myeloma: a new clinical entity Am J Med 117 2004 440 441 (Pubitemid 39369551)
14. R.E. Marx, Y. Sawatari, M. Fortin, and V. Broumand Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention and treatment J Oral Maxillofac Surg 63 2005 1567 1575 (Pubitemid 41525412)
15. C.A. Migliorati, M.A. Siegel, and L.S. Elting Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment Lancet Oncol 7 2006 508 514 (Pubitemid 43779167)
16. T. Hansen, M. Kunkel, and E. Springer Actinomycosis of the jaws - histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis Virchows Arch 51 2007 1009 1017 (Pubitemid 350165265)
17. N.H. Naik, and T.A. Russo Bisphosphonate-related osteonecrosis of the jaw: the role of actinomyces Clin Infect Dis 49 2009 1729 1732
18. P.P. Sedghizadeh, S.K. Kumar, A. Gorur, C. Schaudinn, C.F. Shuler, and J.W. Costerton Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy J Am Dent Assoc 140 2009 1259 1265
19. S.K.S. Kumar, A. Gorur, C. Schaudinn, C.F. Shukler, W.J. Coserton, and P.P. Sedghizadeh The role of microbial biofilms in osteonecrosis of the jaws associated with bisphosphonate therapy Curr Osteoporos Rep 8 2010 40 48
20. S. Patel, S. Choyee, and J. Uyanne Non-exposed bisphosphonate-related osteonecrosis of the jaw: a critical assessment of current definition, staging, and treatment guidelines Oral Dis 18 2012 625 632
21. I. Kaplan, K. Anavi, and Y. Anavi The clinical spectrum of actinomyces-associated lesions of the oral mucosa and jawbones: correlations with histomorphometric analysis Oral Surg Oral Med Oral Pathol Oral Radiol Endod 108 2009 738 746
22. S. Khosla, D. Burr, J. Cauley American Society for Bone and Mineral Research Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research J Bone Miner Res 22 2007 1479 1497
23. R. Rizzoli, N. Burlet, and D. Cahall Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis Bone 42 2008 841 847
24. P.P. Sedghizadeh, K. Stanley, M. Caligiuri, S. Hofkes, B. Lowry, and C.F. Shuler Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry J Am Dent Assoc 140 2009 61 66
25. J.C. Lo, F.S. O'Ryan, N.P. Gordon Predicting Risk of Osteonecrosis of the Jaw with Oral Bisphosphonate Exposure (PROBE) Investigators Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure J Oral Maxillofac Surg 68 2010 243 253
26. S.L. Ruggiero, T.B. Dodson, L.A. Assael, R. Landesberg, R.E. Marx, B. Mehrotra Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw-2009 update Aust Endod J 35 2009 119 130
27. G. Bozas, A. Roy, V. Ramasamy, and A. Maraveyas Osteonecrosis of the jaw after a single bisphosphonate infusion in a patient with metastatic renal cancer treated with sunitinib Onkologie 33 2010 321 323
28. A. Bamias, E. Kastritis, and C. Bamia Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors J Clin Oncol 23 2005 8580 8587 (Pubitemid 46211499)
29. M. Maerevoet, C. Martin, and L. Duck Osteonecrosis of the jaw and bisphosphonates [Letter] N Engl J Med 353 2005 99 102
30. T. Mavrokokki, A. Cheng, B. Stein, and A. Goss Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia J Oral Maxillofac Surg 65 2007 415 423 (Pubitemid 46343586)
31. M. Khamaisi, E. Regev, and N. Yarom Possible association between diabetes and bisphosphonate-related jaw osteonecrosis J Clin Endocrinol Metab 92 2007 1172 1175 (Pubitemid 46465699)
32. F.S. O'Ryan, and J.C. Lo Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes J Oral Maxillofac Surg 70 2012 1844 1853
33. V. Thumbigere-Math, L. Tu, and S. Huckabay A retrospective study evaluating frequency and risk factors of osteonecrosis of the jaw in 576 cancer patients receiving intravenous bisphosphonates Am J Clin Oncol 35 2012 386 392
34. E. Stern, J. Blau, Y. Rusecki, M. Rafaelovsky, and M.P. Cohen Prevalence of diabetes in Israel. Epidemiologic survey Diabetes 37 1988 297 302 (Pubitemid 18065056)
35. G. Chodick, A.D. Heymann, V. Shalev, and E. Kookia The epidemiology of diabetes in a large Israeli HMO Eur J Epidemiol 18 2003 1143 1146 (Pubitemid 38083960)
36. J.W. Hellstein, R.A. Adler, B. Edwards American Dental Association Council on Scientific Affairs Expert Panel on Antiresorptive Agents Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American Dental Association Council on Scientific Affairs J Am Dent Assoc 142 2011 1243 1251
37. K. Zervas, E. Verrou, and Z. Teleiodis Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients Br J Haematol 134 2006 620 623 (Pubitemid 44253605)
38. C. Walter, B. Al-Nawas, and N. Frickhofen Prevalence of bisphosphonate associated osteonecrosis of the jaws in multiple myeloma patients Head Face Med 6 2010 11
39. M. Manfredi, E. Merigo, R. Guidotti, M. Meleti, and P. Vescovi Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis Int J Oral Maxillofac Surg 40 2011 277 284
40. O. Filleul, E. Crompot, and S. Saussez Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases J Cancer Res Clin Oncol 136 2010 1117 1124